177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

计划入组 61 人 · 首次发布于 2025 年 9 月 24 日

Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer

计划入组 70 人 · 首次发布于 2007 年 9 月 26 日

Assessment of the Predictive Value of Anti-beta1AR and Anti-L-CaC Antibodies in the Evolution to Dilated Cardiomyopathy in Patients With Acute Viral Myocarditis

计划入组 300 人 · 首次发布于 2024 年 12 月 19 日

RV-01

bezetabart

GLI1 inhibitors (BetaCat Pharmaceuticals)

Radiopharm's BetaBart Advances Towards FDA Approval for Cancer Trials

Radiopharm Theranostics Increases Stake in Joint Venture as B7H3-Targeting Radiopharmaceutical Betabart Advances to Phase I Trial

AtomVie and Radiopharm Ventures Partner to Advance 177Lu-BetaBart Radioantibody